Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 38 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Oral substitution treatment of injecting opioid users for prevention of HIV infection (Review)Gowing, L.; Farrell, M.; Bornemann, R.; Sullivan, L.; Ali, R.
2012Maintenance drugs to treat opioid dependenceFarrell, M.; Wodak, A.; Gowing, L.
2009Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational studyHallinan, R.; Crettol, S.; Agho, K.; Attia, J.; Besson, J.; Croquette-Krokar, M.; Hammig, R.; Deglon, J.; Byrne, A.; Ray, J.; Somogyi, A.; Eap, C.
2002Relationship between LAAM-methadone preference and treatment outcomesWhite, J.; Danz, C.; Kneebone, J.; La Vincente, S.; Newcombe, D.; Ali, R.
2000Stereoselective quantification of methadone and its major oxidative metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, in human urine using high-performance liquid chromatographyFoster, D.; Somogyi, A.; Bochner, F.
2004Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposureMitchell, T.; Dyer, K.; Newcombe, D.; Salter, A.; Somogyi, A.; Bochner, F.; White, J.
2004(S)-(+)methadone is more immunosuppressive than the potent analgesic (R)-(-)-methadoneHutchinson, M.; Somogyi, A.
2005Characterisation of the in vitro modulation of splenocyte proliferation by non-4,5-epoxymorphinan opioidsHutchinson, M.; Somogyi, A.
2005Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjectsHanna, J.; Foster, D.; Salter, A.; Somogyi, A.; White, J.; Bochner, F.
2000Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsFoster, D.; Somogyi, A.; Dyer, K.; White, J.; Bochner, F.